1qw5: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
New page: left|200px<br /><applet load="1qw5" size="450" color="white" frame="true" align="right" spinBox="true" caption="1qw5, resolution 2.7Å" /> '''Murine inducible nitr...
 
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:1qw5.jpg|left|200px]]<br /><applet load="1qw5" size="450" color="white" frame="true" align="right" spinBox="true"  
[[Image:1qw5.jpg|left|200px]]<br /><applet load="1qw5" size="350" color="white" frame="true" align="right" spinBox="true"  
caption="1qw5, resolution 2.7&Aring;" />
caption="1qw5, resolution 2.7&Aring;" />
'''Murine inducible nitric oxide synthase oxygenase domain in complex with W1400 inhibitor.'''<br />
'''Murine inducible nitric oxide synthase oxygenase domain in complex with W1400 inhibitor.'''<br />


==Overview==
==Overview==
The high level of amino acid conservation and structural similarity in the, immediate vicinity of the substrate binding sites of the oxygenase domains, of the nitric-oxide synthase (NOS) isoforms (eNOSoxy, iNOSoxy, and, nNOSoxy) make the interpretation of the structural basis of inhibitor, isoform specificity a challenge and provide few clues for the design of, new selective compounds. Crystal structures of iNOSoxy and nNOSoxy, complexed with the inhibitors W1400 and Nomega-propyl-l-arginine provide a, rationale for their isoform specificity. It involves differences outside, the immediate active site as well as a conformational flexibility in the, active site that allows the adoption of distinct conformations in response, to interactions with the inhibitors. This flexibility is determined by, isoform-specific residues outside the active site.
The high level of amino acid conservation and structural similarity in the immediate vicinity of the substrate binding sites of the oxygenase domains of the nitric-oxide synthase (NOS) isoforms (eNOSoxy, iNOSoxy, and nNOSoxy) make the interpretation of the structural basis of inhibitor isoform specificity a challenge and provide few clues for the design of new selective compounds. Crystal structures of iNOSoxy and nNOSoxy complexed with the inhibitors W1400 and Nomega-propyl-l-arginine provide a rationale for their isoform specificity. It involves differences outside the immediate active site as well as a conformational flexibility in the active site that allows the adoption of distinct conformations in response to interactions with the inhibitors. This flexibility is determined by isoform-specific residues outside the active site.


==About this Structure==
==About this Structure==
1QW5 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with ZN, HEM, H4B and 14W as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=1QW5 OCA].  
1QW5 is a [http://en.wikipedia.org/wiki/Single_protein Single protein] structure of sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] with <scene name='pdbligand=ZN:'>ZN</scene>, <scene name='pdbligand=HEM:'>HEM</scene>, <scene name='pdbligand=H4B:'>H4B</scene> and <scene name='pdbligand=14W:'>14W</scene> as [http://en.wikipedia.org/wiki/ligands ligands]. Active as [http://en.wikipedia.org/wiki/Nitric-oxide_synthase Nitric-oxide synthase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=1.14.13.39 1.14.13.39] Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1QW5 OCA].  


==Reference==
==Reference==
Line 15: Line 15:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Fedorov, R.]]
[[Category: Fedorov, R.]]
[[Category: Ghosh, D.K.]]
[[Category: Ghosh, D K.]]
[[Category: Hartmann, E.]]
[[Category: Hartmann, E.]]
[[Category: Schlichting, I.]]
[[Category: Schlichting, I.]]
Line 24: Line 24:
[[Category: murine inosoxy inhibitor complex]]
[[Category: murine inosoxy inhibitor complex]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Wed Nov 21 01:03:09 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 14:44:23 2008''